Print Friendly, PDF & Email

The Center for Medicare Advocacy (the Center) submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding proposed rules affecting durable medical equipment, prosthetics, orthotics and supplies (DMEPOS). The Center requested that CMS:

  • Seek to maximize beneficiary access to DMEPOS;
  • Clarify supplier responsibilities to provide beneficiaries with appropriate products and timely services;
  • Develop appropriate enforcement mechanisms to ensure suppliers are following regulations and policies in order to protect both beneficiaries and the Medicare program;
  • Properly communicate to suppliers that the proposed payment strategy, Lead Item Pricing, will be monitored to prevent adaptive profit-making that would result in reduced access to equipment or supplies; and
  • Define “Value” in DMEPOS supplier contracts as a multi-faceted CMS commitment that is grounded in more than short-term financial results and includes effective/quality products, responsive service, follow-up, long-term results and long-term cost savings.

See our full comments at:

September 13 – K. Holt

Comments are closed.